Target intelligence / Profile preview

Cellular proteins and other nucleophilic macromolecules

Molecular classification
Other, Proteins, Nucleic acids
01

Overview

Cellular proteins and other nucleophilic macromolecules encompass a diverse array of biological polymers, including DNA, RNA, and various proteins, characterized by the presence of electron-rich (nucleophilic) functional groups. These groups, such as the N7 position of guanine in DNA or sulfhydryl groups in cysteine residues, are primary sites for covalent modification by electrophilic drugs and reactive metabolites [StatPearls: Alkylating Agents, 2023]. This broad-spectrum interaction is the fundamental mechanism for several classes of chemotherapy, including alkylating agents and platinum-based compounds, which disrupt cellular replication and function to treat various cancers [NCBI: Alkylating Agents]. However, because these interactions are often non-selective, they lead to significant clinical challenges, including systemic toxicity, mutagenicity, and the risk of secondary cancers [PubMed: Covalent Binding and Toxicity]. Consequently, this term does not refer to a single, discrete therapeutic target but rather a general chemical vulnerability within the cell that is exploited for cytotoxic effect.

Other names
Cellular nucleophilesNucleophilic biological macromoleculesNucleophilic targetsBiological nucleophiles
02

Mechanism of action

Covalent modification via alkylation, arylation, or coordination complex formation at nucleophilic functional groups such as thiols, amines, hydroxyls, and phosphates.

03

Biological functions

OtherEnzymatic catalysisGenetic information storageStructural integritySignal transduction
04

Disease associations

CancerInfectionToxicity
05

Safety considerations

MutagenicityCarcinogenicityTeratogenicityMyelosuppressionNon-specific systemic toxicitySecondary malignancies
06

Interacting drugs

Cyclophosphamide

7 more in the full profile.

07

Biomarkers

DNA adductsProtein adducts (e.g., Hemoglobin adducts)Glutathione (GSH) depletion8-hydroxy-2-deoxyguanosine (8-OHdG)

Beyond the preview

Go deeper on Cellular proteins and other nucleophilic macromolecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular proteins and other nucleophilic macromolecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call